PCSA Processa Pharmaceuticals, Inc.
Price Chart
Executive Summary
Two C-suite insiders at Processa Pharmaceuticals made open-market purchases totaling ~$9K on May 29, 2026, at $2.57/share. This is a small cluster relative to the $7M market cap (~0.13%), but the fact that both are senior officers buying on the same day at the same price suggests coordinated conviction. The company has a history of insider buying ($33K over 30 days) and a bullish analyst consensus (86% buy), but past cluster reports on PCSA have underperformed at T+20 (-1.24% avg).
Key Financial Metrics
Actionable Insight
Insider cluster buys at a micro-cap biotech with strong analyst support are a modest positive signal. However, past PCSA cluster reports have negative T+20 alpha (-9.00% vs SPY). Watch for upcoming catalysts (pipeline updates, financing news) that could explain the buying. The small dollar amount limits conviction — treat as a supportive data point, not a standalone trade signal.
Key Facts
- Chief Administrative Officer Guy Wendy purchased 1,829 shares at $2.57 for $4,701
- Chief Business & Strategy Officer Lin Patrick purchased 1,582 shares at $2.57 for $4,066
- Total cluster value: ~$9K, representing ~0.13% of $7M market cap
- Both trades occurred on the same day (May 29, 2026) at the same price
- 30-day insider buying totals $33K across 7 transactions
- Analyst consensus is 86% bullish (6 buy, 1 hold)
Financial Impact
~$9K in insider purchases, ~0.13% of market cap
Risk Factors
- Micro-cap biotech with $7M market cap — high bankruptcy/dilution risk
- Past cluster reports on PCSA have underperformed at T+20 (-1.24% avg return)
- Small absolute dollar amount ($9K) may reflect liquidity constraints, not strong conviction
- No disclosed catalyst — buying could be routine accumulation
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PCSA-1780347459824 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
5d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
May 19, 2026
18d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
May 19, 2026
18d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
Apr 30, 2026
5w ago
|
Insider Cluster
| $2.70 $2.64 | ▼ −2.22% | ▼ −7.19% | $2.52 (−6.67%) |
|
Apr 15, 2026
7w ago
|
Insider Cluster
| $2.96 $2.56 | ▼ −13.51% | ▼ −19.56% | $2.52 (−14.86%) |
|
Mar 31, 2026
9w ago
|
Insider Cluster
| $2.53 $2.65 | ▲ +4.95% | ▼ −4.47% | $2.52 (−0.20%) |
|
Mar 31, 2026
9w ago
|
Insider Cluster
| $2.53 $2.75 | ▲ +8.89% | ▼ −0.53% | $2.52 (−0.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access